WELL Health Technologies (TSE:WELL – Get Free Report) had its target price raised by equities researchers at Canadian Imperial Bank of Commerce from C$5.50 to C$6.00 in a research note issued to investors on Wednesday,BayStreet.CA reports. The brokerage currently has an “outperformer” rating on the stock. Canadian Imperial Bank of Commerce’s price objective points to a potential upside of 23.71% from the company’s previous close.
Several other research firms have also recently issued reports on WELL. Scotiabank reduced their target price on WELL Health Technologies from C$7.00 to C$6.50 and set an “outperform” rating on the stock in a research note on Wednesday, February 4th. Stifel Nicolaus boosted their target price on WELL Health Technologies from C$8.00 to C$8.25 and gave the company a “buy” rating in a research note on Wednesday. Three analysts have rated the stock with a Buy rating, Based on data from MarketBeat.com, WELL Health Technologies has an average rating of “Buy” and an average target price of C$6.92.
View Our Latest Stock Analysis on WELL
WELL Health Technologies Trading Down 0.6%
WELL Health Technologies (TSE:WELL – Get Free Report) last posted its earnings results on Thursday, May 7th. The company reported C$0.06 earnings per share (EPS) for the quarter. WELL Health Technologies had a return on equity of 3.15% and a net margin of 1.82%.The firm had revenue of C$368.26 million for the quarter. As a group, sell-side analysts forecast that WELL Health Technologies will post 0.3000698 EPS for the current fiscal year.
About WELL Health Technologies
WELL Health Technologies Corp is the owner and operator of a portfolio of Primary Hclinics delivering healthcare-related services It operates through below segments: clinical operations and allied health, Electronic medical record (EMR), Billing and revenue cycle management solutions, Digital apps, Cybersecurity, CRH, MyHealth, and corporate/shared services. Its segments are grouped in three divisions; Omni-channel Patient Services – Primary includes clinical operations and allied health. Omni-channel Patient Services – Specialized comprises CRH and MyHealth under two segments.
Further Reading
- Five stocks we like better than WELL Health Technologies
- Palo Alto Networks Accelerates Growth 31% on AI Demand
- NVIDIA, Marriott, and PCA Just Delivered Big News for Income Investors
- Motorola’s $1.5B Bet to Own the Skies
- AI’s Power Crunch Is Putting Uranium Energy Back on Investors’ Watchlists
Receive News & Ratings for WELL Health Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WELL Health Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
